No Data
No Data
A-shares fluctuate丨Traditional Chinese Medicine stocks rise, Jiuzhitang Co.,Ltd. hits the limit up.
On May 15, according to Gelonghui, Traditional Chinese Medicine in the A-share market surged, with Jiuzhitang Co.,Ltd. hitting the daily limit, and Zhejiang Shouxiangu Pharmaceutical, Mayinglong Pharmaceutical Group, Zhejiang Jolly Pharmaceutical, Zhejiang Wecome Pharmaceutical, Guizhou Yibai Pharmaceutical, and Lanzhou Foci Pharmaceutical all experiencing gains. In terms of news, China Securities Co.,Ltd. pointed out that against the backdrop of a reshaped global landscape, the China Meheco Group needs to "base itself domestically while expanding abroad," promote autonomous and controllable technology, accelerate international layout, respond to tariff policies and geopolitical challenges, and capture opportunities for transformation in the global Industry Chain. The institution is Bullish about pharmaceutical companies stabilizing their domestic foundations, actively participating in industry integration, and externally seizing rhythms and pathways to actively explore overseas markets. (Gelonghui)
Express News | Another wave of companies have revoked Special Treat and *Special Treat.
Express News | Special Treat Jiuzhitang: Since the market opened on May 7, the other risk warnings have been lifted, and the stock short name has been changed to "Jiuzhitang".
Jiuzhitang Co.,Ltd.: 2025 First Quarter Report
Express News | ST Jiuzhi: In the first quarter, the net income attributable to the parent company was 0.117 billion yuan, a year-on-year decrease of 19.4%.
Express News | Special Treat Jiuzhi: The USA cell company business that the company invested in has not yet been directly affected by the USA tariff policy.